Omnicell, Inc. (OMCL)
Largest Insider Buys in Sector
OMCL Stock Price History Chart
OMCL Stock Performance
About Omnicell, Inc.
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software …
Insider Activity of Omnicell, Inc.
Over the last 12 months, insiders at Omnicell, Inc. have bought $0 and sold $0 worth of Omnicell, Inc. stock.
On average, over the past 5 years, insiders at Omnicell, Inc. have bought $150,479 and sold $13.71M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,000 shares for transaction amount of $295,040 was made by LIPPS RANDALL A (CHAIRMAN, PRESIDENT AND CEO) on 2023‑06‑08.
List of Insider Buy and Sell Transactions, Omnicell, Inc.
| 2023-06-09 | Sale | EVP, EXECUTIVE ADVISOR | 7,951 0.0179% | $73.14 | $581,568 | -52.09% | ||
| 2023-06-08 | CHAIRMAN, PRESIDENT AND CEO | 4,000 0.0089% | $73.76 | $295,040 | -52.90% | |||
| 2023-03-07 | Sale | director | 9,797 0.0219% | $53.97 | $528,718 | +0.99% | ||
| 2023-03-07 | Sale | director | 13,115 0.0295% | $54.24 | $711,333 | +0.99% | ||
| 2022-12-27 | Sale | EVP, CHIEF COMMERCIAL OFFICER | 945 0.0022% | $48.28 | $45,625 | +19.04% | ||
| 2022-12-16 | Sale | EVP, CHIEF COMMERCIAL OFFICER | 4,436 0.0098% | $47.79 | $211,990 | +14.94% | ||
| 2022-12-01 | Sale | CHAIRMAN, PRESIDENT AND CEO | 2,500 0.0056% | $50.78 | $126,942 | +9.91% | ||
| 2022-11-28 | Sale | EVP, CHIEF COMMERCIAL OFFICER | 1,793 0.0043% | $51.46 | $92,268 | +15.18% | ||
| 2022-08-26 | Sale | EXECUTIVE V P& CFO | 15,481 0.0349% | $108.29 | $1.68M | -43.96% | ||
| 2022-08-22 | Sale | EXECUTIVE V P& CFO | 11,000 0.0246% | $105.93 | $1.17M | -42.41% | ||
| 2022-08-16 | Sale | CHAIRMAN, PRESIDENT AND CEO | 13,000 0.0292% | $111.04 | $1.44M | -44.04% | ||
| 2022-06-15 | Sale | EVP, CHIEF COMMERCIAL OFFICER | 3,208 0.0071% | $110.01 | $352,912 | -42.32% | ||
| 2022-03-14 | Sale | EVP, Chief Commercial Officer | 2,525 0.0058% | $133.11 | $336,103 | -25.23% | ||
| 2021-12-16 | Sale | EVP, Chief Commercial Officer | 3,628 0.0083% | $176.90 | $641,778 | -36.55% | ||
| 2021-12-16 | Sale | EVP & Chief Legal & Admin | 1,063 0.0024% | $176.88 | $188,019 | -36.55% | ||
| 2021-12-08 | Sale | Chief Accounting Officer & VP | 6,976 0.0158% | $180.76 | $1.26M | -38.34% | ||
| 2021-12-07 | Sale | Executive V P& CFO | 8,517 0.0196% | $181.15 | $1.54M | -37.50% | ||
| 2021-12-07 | Sale | Chief Accounting Officer & VP | 1,179 0.0027% | $181.14 | $213,564 | -37.50% | ||
| 2021-11-16 | Sale | Chief Accounting Officer & VP | 38,585 0.0879% | $180.36 | $6.96M | -36.31% | ||
| 2021-11-02 | Sale | EVP & Chief Legal & Admin | 5,358 0.0125% | $180.00 | $964,440 | -33.71% |
Insider Historical Profitability
| LIPPS RANDALL A | CHAIRMAN, PRESIDENT AND CEO | 318768 0.6882% | $43.80 | 2 | 173 | <0.0001% |
| WHITTERS JOSEPH E | director | 38886 0.084% | $43.80 | 2 | 4 | +36.39% |
| Seim Robin Gene | Director | 30049 0.0649% | $43.80 | 1 | 54 | +11.39% |
| LINDHOLM RANDY D | director | 27763 0.0599% | $43.80 | 4 | 14 | <0.0001% |
| YOUNGER WILLIAM H JR | director | 20860 0.045% | $43.80 | 3 | 15 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $234.03M | 17.43 | 8.01M | +1.51% | +$3.49M | 0.01 | |
| The Vanguard Group | $165.2M | 12.31 | 5.65M | +1.44% | +$2.35M | <0.01 | |
| Cadian Capital Management LP | $67.83M | 5.05 | 2.32M | +3,470.11% | +$65.93M | 2.41 | |
| State Street | $59.9M | 4.46 | 2.05M | +1.83% | +$1.08M | <0.01 | |
| Champlain Investment Partners, LLC | $51.25M | 3.82 | 1.75M | +15.96% | +$7.05M | 0.29 |